toona
sinensi
ts
also
known
cedrela
sinensi
belong
meliacea
famili
compound
identifi
ts
leav
possess
wide
rang
biolog
function
hypoglycem
effect
antildl
glyc
activ
antioxid
activ
inhibit
sudden
acut
respiratori
syndrom
sar
coronaviru
replic
howev
effect
cancer
cell
well
explor
studi
understand
cytotox
effect
molecular
mechan
stimul
ts
leaf
extract
fraction
employ
three
differ
nonsmallcel
lung
cancer
nsclc
cell
line
cell
lung
adenocarcinoma
cell
lung
larg
cell
carcinoma
cell
lung
squamou
cell
carcinoma
valu
vari
three
cell
line
least
ic
valu
observ
exposur
nsclc
cell
caus
cellcycl
arrest
phase
caus
apoptosi
moreov
treatment
decreas
cellcycl
regul
cyclin
protein
regul
express
dosedepend
manner
thu
apoptosi
confirm
cell
morpholog
peak
accumul
poli
adenosin
diphosph
adp
ribos
polymeras
parp
cleavag
propidium
iodid
pi
annexinv
doubl
stain
termin
deoxynucleotidyl
transferasemedi
dutp
nick
endlabel
tunel
assay
decreas
protein
level
concurr
increas
bax
protein
level
cell
line
addit
tumoricid
effect
measur
use
xenograft
model
week
treatment
variou
regimen
caus
regress
tumor
taken
togeth
vitro
vivo
studi
reveal
potent
inhibitor
nsclc
growth
provok
result
suggest
better
nutriceut
singlet
along
withdoublet
agent
taxan
vinorelbin
gemcitabin
treat
nsclc
translat
research
abbrevi
cdk
cyclindepend
kinas
ecl
enhanc
chemiluminesc
fac
fluorescenceactiv
cell
sort
fb
fetal
bovin
serum
ic
half
maxim
inhibitori
concentr
mtt
tetrazolium
dye
nsclc
nonsmallcel
lung
cancer
parp
poli
adenosin
diphosph
adp
ribos
polymeras
pb
phosphatebuff
salin
pi
propidium
iodid
human
ovarian
cancer
cell
rt
room
temperatur
ts
toona
sinensi
ts
leaf
extract
tunel
termin
deoxynucleotidyl
transferasemedi
dutp
nick
endlabel
world
wide
lung
carcinoma
one
lead
caus
cancer
relat
death
men
women
compar
subtyp
small
cell
lung
cancer
non
smallcel
lung
cancer
nsclc
repres
lung
neoplasm
major
patient
present
advanc
unresect
metastat
diseas
approxim
unselect
patient
expect
activ
five
year
thu
chemotherapeut
benefit
develop
new
antilung
cancer
drug
prognosi
advanc
nsclc
becom
import
insist
issu
cellcycl
critic
regul
cell
growth
cell
prolifer
follow
dna
damag
proper
function
cellcycl
machineri
cyclindepend
kinas
cdk
posit
regul
cyclin
neg
regul
cyclin
depend
kinas
inhibitor
well
known
drug
target
cyclin
depend
kinas
use
better
anticanc
agent
day
natur
occur
substanc
recogn
antioxid
cancerprevent
agent
even
cancer
therapi
drug
taxol
flavopiridol
bioactiv
substanc
exert
anticanc
activ
block
cellcycl
progress
trigger
tumor
cell
apoptosi
similarli
substanc
induc
phase
arrest
consid
potenti
candid
treat
develop
cancer
slowli
howev
chemotherapi
substanti
improvis
surviv
lung
cancer
patient
clear
chemotherapi
reach
plateau
activ
treat
nsclc
toona
sinesi
ts
tradit
chines
herb
leaf
extract
possess
antiprolif
properti
human
lung
adenocarcinoma
cell
ovarian
cancer
cell
human
premyelocyt
leukemia
cell
recent
report
found
leaf
extract
fraction
could
inhibit
cell
prolifer
vitro
vivo
support
former
data
present
studi
cellular
molecular
mechan
action
human
cancer
cell
examin
use
vitro
vivo
model
result
indic
inhibit
cellcycl
progress
induct
apoptot
cell
death
contribut
antiprolif
effect
nsclc
cell
plant
materi
prepar
leav
use
studi
obtain
ts
grown
tuku
yunlin
counti
taiwan
leav
collect
wash
briskli
water
fraction
extract
mention
previou
studi
cell
viabil
assay
lung
adenocarcinoma
cell
line
lung
squamou
cell
line
lung
largecanc
cell
obtain
american
type
cultur
collect
rockvil
md
cellswel
cellswel
cell
cellswel
seed
plate
grown
rpmi
medium
supplement
heat
inactiv
fetal
bovin
serum
fb
iu
ml
penicillin
mmoll
lglutamin
mmoll
hepe
mmoll
sodium
pyruv
co
incub
c
overnight
cell
incub
fb
media
differ
concentr
h
h
cell
growth
estim
colorimetr
assay
base
conserv
tetrazolium
dye
mtt
blue
formazan
product
live
mitochondria
western
blot
analysi
treatment
cell
rins
icecold
phosphatebuff
salin
pb
harvest
lysi
buffer
min
ice
cellular
lysat
centrifug
g
min
protein
concentr
lysat
determin
use
bicinchonin
acid
bca
protein
assay
kit
pierc
rockford
ill
procedur
western
blot
slightli
modifi
previou
studi
blot
incub
variou
primari
glanc
commentari
yang
cj
et
al
chemotherapeut
benefit
prognosi
advanc
nonsmallcel
lung
cancer
nsclc
remain
promot
toona
sinensi
ts
tradit
chines
herb
possess
varieti
biolog
function
flow
cytometri
analysi
show
ts
leaf
extract
treatment
induc
phase
arrest
nsclc
cell
accompani
downregul
protein
level
cyclindepend
protein
level
decreas
wherea
cell
show
increas
activ
apoptosi
confirm
cell
morpholog
peak
accumul
poli
adenosin
diphosph
adp
ribos
polymeras
parp
cleavag
propidium
iodid
pi
annexinv
doubl
stain
tunel
assay
bax
express
furthermor
tumoricid
effect
confirm
nude
mice
model
thu
conclud
could
taken
nutriceut
efficaci
candid
develop
anticanc
drug
antibodi
cyclin
bax
santa
cruz
biotechnolog
santa
cruz
calif
h
room
temperatur
rt
incub
peroxidaseconjug
secondari
antibodi
addit
h
signal
blot
develop
use
enhanc
chemiluminesc
ecl
system
amersham
bioscienc
corp
piscataway
nj
analysi
cellcycl
distribut
cell
cultur
absenc
presenc
mgml
h
fb
media
cell
fix
ethanol
stain
propidium
iodid
pi
cellcycl
distribut
analyz
fluorescenceactiv
cell
sort
fac
flow
cytometri
becton
dickinson
mountain
view
calif
apoptosi
assay
cell
cultur
plate
fb
media
incub
vehicl
differ
amount
h
incub
detach
cell
collect
centrifug
attach
cell
harvest
trypsin
cell
pool
analyz
degrad
parp
describ
previous
measur
apoptosi
flow
cytometri
treatment
annexinv
annexin
vfitc
mgml
strong
biotech
taipei
taiwan
stain
perform
detect
apoptot
cell
cell
wash
cold
hepe
buffer
mmoll
hepesnaoh
ph
mmoll
nacl
mmoll
cacl
centrifug
g
min
cell
pellet
resuspend
ml
stain
solut
ml
annexinvfluo
ml
pi
ml
hepe
buffer
incub
min
rt
dark
annexinv
pi
fluoresc
intens
analyz
flow
cytometri
cell
evalu
sampl
termin
deoxynucleotidyl
transferasemedi
dutp
nick
endlabel
tunel
assay
tunel
assay
use
detect
dna
strand
break
detect
carri
accord
instruct
tac
tm
tdtdab
situ
apoptosi
detect
kit
trevigen
gaithersburg
md
briefli
cell
rins
pb
fix
buffer
formaldehyd
rt
min
fix
section
pretreat
h
end
label
perform
tdt
label
reaction
mix
c
h
nuclei
exhibit
dna
fragment
visual
incub
benzidin
dab
min
lastli
section
counterstain
methyl
green
observ
optic
microscop
zeiss
carl
zeiss
oberkochen
germani
nuclei
apoptot
cell
stain
dark
brown
nude
mice
experi
anim
experi
perform
accord
guidelin
set
institut
guid
care
use
laboratori
anim
kaohsiung
medic
univers
male
balbcanu
nude
mice
wk
old
hous
pathogen
free
barrier
facil
tumor
induc
subcutan
sc
inject
cell
ml
pb
cell
line
right
flank
tumor
visual
small
nodul
site
inject
appear
day
cell
inject
tumor
bear
nude
mice
randomli
distribut
group
n
mice
treat
group
po
inject
low
dosag
gkg
bwt
ii
high
dosag
gkg
bwt
iii
mice
treat
high
dose
ip
mgkg
bwt
control
group
treat
equal
volum
vehicl
doubl
distil
water
ddw
anoth
set
experi
anim
pretreat
vehicl
day
therapeut
prevent
experi
tumor
induc
subcutan
sc
inject
mention
day
inject
nude
mice
bear
tumor
randomli
distribut
group
control
group
receiv
vehicl
ddw
receiv
group
gkg
bwt
treat
day
mice
pretreat
post
treat
ddw
group
post
treat
gkg
bwt
transplant
tumor
size
measur
use
calip
tumor
volum
estim
accord
formula
tumor
volum
larger
diamet
l
small
diamet
statist
analysi
data
present
mean
standard
deviat
indic
number
separ
experi
analysi
varianc
anova
follow
dunnett
test
pair
wise
comparison
statist
signific
defin
pvalu
less
test
cytotox
lung
cancer
cell
line
nsclc
cell
treat
without
differ
time
point
ic
valu
treat
tumor
cell
h
mgml
cell
mgml
cell
mgml
cell
respect
compar
h
time
point
h
treatment
show
better
inhibitori
effect
lung
cancer
cell
line
among
cell
line
cell
display
lower
ic
valu
fig
b
experi
show
could
induc
high
cytotox
nsclc
cell
effect
cellcycl
distribut
cellcyclerel
protein
examin
underli
mechan
cell
prolifer
inhibit
cellcycl
distribut
evalu
use
flow
cytometr
analysi
nsclc
cell
show
signific
increas
compar
control
group
fig
next
analyz
effect
cellcycl
protein
result
show
could
inhibit
cyclin
protein
level
nsclc
therebi
upregul
express
level
decreas
cyclin
coupl
increas
signific
cell
compar
cell
line
fig
thu
treatment
induc
cellcycl
arrest
associ
result
cellcyclerel
protein
apoptot
effect
cancer
cell
line
four
separ
assay
appli
investig
induct
apoptosi
nsclc
treatment
fig
cell
treat
h
mgml
analyz
apoptosi
tunel
cell
morpholog
peak
accumul
cleavag
parp
piannexinv
doubl
stain
cell
morpholog
determin
analyz
effect
treatment
induc
apoptosi
untreat
nsclc
apoptot
bodi
observ
substanc
cytosol
releas
media
timedepend
effect
fig
treatment
induc
apoptosi
shown
tunel
assay
fig
b
apoptot
featur
observ
treat
cell
includ
brownstain
fragment
nuclei
irregularshap
cell
irregular
cytoplasm
membran
addit
percentag
annexin
vposit
cell
indic
earli
apoptosi
increas
control
cell
similarli
increas
apoptosi
control
cell
cell
observ
moreov
treatment
increas
percentag
cell
posit
annexin
v
propidium
iodid
hallmark
late
apoptosi
control
cell
respect
fig
c
western
blot
analysi
perform
evalu
activ
parp
downstream
mitochondriamedi
apoptot
pathway
fig
observ
increas
cleavag
product
respect
concentr
result
consist
cell
line
use
taken
togeth
conclud
induc
apoptosi
nsclc
cell
effect
famili
protein
well
known
famili
member
induc
inhibit
apoptosi
western
blot
analysi
show
increas
concentr
decreas
protein
express
cell
line
time
treat
cell
line
show
increas
bax
protein
level
compar
respect
control
fig
result
indic
protein
famili
might
involv
mediat
apoptosi
inhibit
tumor
growth
nude
mice
understand
effect
nsclc
cell
equal
number
cell
inject
right
flank
nude
mice
tumor
visual
small
nodul
site
inject
appear
day
cell
inject
cell
line
fail
induc
tumor
format
compar
control
mm
treatment
intraperitoni
day
show
reduct
tumor
size
mm
similar
result
found
low
mm
high
dose
mm
administr
via
po
fig
result
reveal
caus
tumor
shrinkag
dose
depend
manner
test
prevent
effect
tumor
format
mice
pretreat
vehicl
control
day
inocul
cell
group
treat
use
distil
water
addit
day
observ
tumor
shrinkag
compar
control
distil
water
control
tumor
volum
mm
pretreat
posttreat
distil
water
show
reduct
tumor
volum
mm
pre
post
treat
mice
show
reduct
tumor
size
mm
fig
b
hepat
kidney
renal
toxic
observ
administr
mice
po
ip
data
shown
chemotherapi
usual
best
choic
treat
latestag
nsclc
howev
appear
chemotherapeut
drug
resist
result
poor
remedi
low
surviv
rate
applic
chines
herb
medicin
treat
malign
diseas
dramat
increas
recent
year
articl
extract
ts
leav
demonstr
antiprolif
activ
induc
apoptosi
nsclc
cell
line
varieti
phytochem
compon
isol
character
ts
leav
includ
gallic
acid
methyl
gallic
acid
glucopyranosid
glucopyranosid
methyl
gallat
ethyl
gallat
kaempferol
quercitrin
rutin
catechin
furthermor
polyphenol
limonoid
methyl
gallat
found
antioxid
activ
inhibit
lipid
peroxid
gallic
acid
major
compound
found
antiinflammatori
antimutagen
anticarcinogen
effect
found
induc
apoptosi
cancer
cell
antioxid
bioactiv
compon
ts
methyl
gallat
limonoid
catechin
also
shown
anticanc
effect
recent
studi
indic
extract
tumor
accumul
nude
mice
show
tumor
shrinkag
ts
leav
provid
antioxid
capabl
decreas
reactiv
oxygen
speci
damag
subsequ
induc
tumor
cell
apoptosi
result
strengthen
potenti
new
altern
medicin
anticanc
therapi
current
studi
show
tumor
cell
significantli
sensit
chemotherapeut
agent
treat
differ
half
maxim
inhibitori
concentr
ic
observ
among
nsclc
cell
line
lowest
concentr
ic
result
could
caus
differ
cell
line
characterist
test
underli
mechan
cell
growth
inhibit
treatment
relat
cellcycl
chang
perform
cellcycl
analysi
cell
dose
induc
phase
arrest
cell
line
therefor
phase
arrest
cell
cycl
consid
pathway
suppress
growth
nsclc
cell
similar
phenomenon
sub
phase
arrest
demonstr
cell
result
evid
specif
cellcycl
arrest
depend
via
po
group
mice
treat
high
dose
gkg
bwt
via
po
group
mice
treat
high
dose
mgkg
bwt
intraperiton
b
nude
mice
pretreat
po
vehicl
ddw
day
nude
mice
inocul
adenocarcinoma
skin
tumor
format
control
group
receiv
distil
water
day
group
treat
addit
day
follow
group
tsdw
receiv
doubl
distil
water
group
b
tst
receiv
gkg
bwt
addit
day
data
present
mean
sd
n
p
repres
level
signific
differ
control
treatment
p
repres
level
signific
differ
group
b
day
differ
cell
type
dosag
exposur
time
cellcycl
arrest
nsclc
cell
accompani
alter
cellcycleregul
protein
agent
inhibit
cdk
activ
alter
level
could
caus
cellcycl
arrest
strategi
import
potenti
use
novel
anticanc
drug
cdk
cyclin
major
molecul
requir
proper
cellcycl
event
cyclincdk
complex
phosphoryl
uniqu
set
substrat
requir
continu
cellcycl
progress
among
cdk
regul
cell
cycl
activ
associ
dtype
cyclin
cyclin
e
progress
transit
found
express
decreas
significantli
compar
cell
line
overexpress
cyclin
found
variou
type
cancer
includ
lung
cancer
hepatoma
breast
cancer
uric
bladder
cancer
esophag
cancer
increas
express
cyclin
play
critic
role
tumor
develop
mainten
malign
phenotyp
patient
cyclin
tumor
shorter
surviv
cyclin
tumor
surviv
rate
respect
treatment
nsclc
cell
result
downregul
cyclin
dosedepend
manner
increas
express
cyclindepend
inhibitor
consist
cellcycl
analysi
morpholog
chang
apoptosi
consid
result
complex
cellular
biochem
pathway
apoptosi
machineri
initi
multipl
pathway
use
differ
initi
event
insult
studi
apoptosi
confirm
morpholog
studi
phosphatidylserin
extern
parp
cleavag
tunel
assay
fact
presenc
cleav
parp
one
util
diagnost
detect
apoptosi
mani
cell
type
particular
fragment
contain
dna
bind
domain
may
facilit
apoptot
process
block
access
dna
repair
enzym
fragment
chromatin
cell
show
induct
cleav
dna
fragment
addit
parp
cleavag
stream
mitochondri
mediat
apoptosi
pathway
also
observ
treatment
cell
line
decreas
protein
express
increas
bax
protein
level
similarli
yang
et
al
report
induc
depend
mitochondri
pathway
treat
cell
confirm
inhibitori
effect
nsclc
induc
cell
subcutan
inject
athym
nude
mice
except
cell
fail
induc
cancer
nude
mice
studi
variou
regimen
administr
per
ip
nude
mice
caus
tumor
shrinkag
contrast
mice
treat
vehicl
alon
thu
exhibit
antiprolif
antitumorogen
effect
without
renal
hepatotox
vivo
studi
confirm
safe
effect
antiprolif
compound
complimentari
altern
medicin
conclus
current
studi
demonstr
human
nsclc
cell
line
becam
sensit
treatment
vitro
vivo
model
find
suggest
extract
ts
could
taken
nutriceut
prevent
cancer
may
promis
chemoprevent
agent
human
nsclc
